The AIA Advocate Newsletter
From: The Research and Editorial Staff of
The Association for Investor Awareness, Inc.
The AIA “Advocate For Absolute Returns”, a publication of The Association for Investor Awareness, tracks market trends, industry news, the SEC, global trade and finance and Washington developments for you because they affect your investments. But who doesn’t? Many sources report these issues as abstract facts.
We feel that’s not enough…
The AIA Advocate’s job is to warn you of what’s important and how these developments translate to ground-level forces and threats that directly affect your wealth as well as your current investment opportunities. Not just information, but information you can use.
Stella Diagnostics, Inc. (OTC: SLDX) @ 07/22/2022 – shares positioned for significant upward movement
Research agreements with Mayo Clinic and University of Kansas Medical Center puts industry spotlight on up-and-coming bio-tech Stella Diagnostics, Inc. (OTC: SLDX), is focused on developing molecular diagnostic strategies for early detection of esophageal cancer. The Company, in collaboration with the Mayo Clinic, Kansas University Medical Center and mProbe, Inc.,…
Virtual Interactive Technologies Corp (OTC VRVR) 03/16/2022
VRVR is a multi-platform video game production, publishing, and technology company. VRVR has five revenue producing video game titles and several more in development, including a multi-year, multi-game agreement with Duane “Dog” Chapman, aka “Dog the Bounty Hunter.” Company Summary VRVR finances the development of video game projects to be…
Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) 01/10/2022
RTSL seems well-positioned for an upward share price movement Company Summary RTSL is a growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds. The Company has developed a new method of formulating and manufacturing pressurized metered dose inhalers (pMDI) that contain and properly aerosolize proprietary formula of one…
QSAM Biosciences, Inc. (OTCQB: QSAM) @ 01/11/2022
Next Generation Nuclear Technology Focused on the Eradication of Bone Cancer Management believes its initial technology, CycloSam® has a strong pathway to commercialization in a Global Market that is valued at $12.6 Billion* Company Summary: QSAM Biosciences, Inc. (OTCQB: QSAM), is developing next generation nuclear medicines for the treatment of cancer…
Pure Harvest Corporate Group, Inc. (OTCQB: PHCG)
Company Summary: Pure Harvest (OTCQB: PHCG) is a publicly traded holding company involved in all cycles of cannabis and CBD development. The Company is committed to providing the highest quality products, ethical growing standards, environmental awareness, and corporate integrity. Pure Harvest intends to develop into a large scale vertically integrated…
Nuclear Technology Targeting Bone Cancer Receives European Patent Office Approval
Put this biotech on your radar immediately… here’s why…! QSAM Biosciences, Inc. (OTCQB: QSAM), is developing next generation nuclear technologies for the treatment of bone cancer. The European Patent Office (EPO) has allowed the first patent covering “DOTMP kit formulations for radioisotopes.” This is the first patent outside the United…